NeuroVive buys stake in Isomerase Therapeutics
Lund, Sweden, 14 January 2016 - NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, announces the partial acquisition of British company Isomerase Therapeutics ("Isomerase") with t ...